Njoku, V.C.E.; Lee, Y.; Ramesh, J.; Kubatka, P.; Büsselberg, D.
Precision Antibody Therapy in Gastric and Gastroesophageal Cancer: Targeting FGFR2b, CLDN18.2, and VEGFR2. Cells 2025, 14, 1672.
https://doi.org/10.3390/cells14211672
AMA Style
Njoku VCE, Lee Y, Ramesh J, Kubatka P, Büsselberg D.
Precision Antibody Therapy in Gastric and Gastroesophageal Cancer: Targeting FGFR2b, CLDN18.2, and VEGFR2. Cells. 2025; 14(21):1672.
https://doi.org/10.3390/cells14211672
Chicago/Turabian Style
Njoku, Vivian Chetachi Eziefula, Yein Lee, Joytish Ramesh, Peter Kubatka, and Dietrich Büsselberg.
2025. "Precision Antibody Therapy in Gastric and Gastroesophageal Cancer: Targeting FGFR2b, CLDN18.2, and VEGFR2" Cells 14, no. 21: 1672.
https://doi.org/10.3390/cells14211672
APA Style
Njoku, V. C. E., Lee, Y., Ramesh, J., Kubatka, P., & Büsselberg, D.
(2025). Precision Antibody Therapy in Gastric and Gastroesophageal Cancer: Targeting FGFR2b, CLDN18.2, and VEGFR2. Cells, 14(21), 1672.
https://doi.org/10.3390/cells14211672